Mesothelioma Risk to War Survivors Highlighted by Journalist’s Case
A new Italian case study highlights the mesothelioma risk to war survivors, including journalists and bystanders. In an article in BMJ Case Reports, researchers from Rome detail the case of a war journalist who contracted mesothelioma after more than ten years in the field. The male journalist worked in war zones in the Far and Near East. He inhaled a range of toxic substances including asbestos in the dust and smoke from destroyed buildings. The new case report is a sobering reminder that bombs and bullets are not the only deadly threats in war-torn regions. Asbestos dust poses an often-overlooked mesothelioma risk to war survivors. Asbestos and its Link to Mesothelioma Asbestos is a naturally-occurring mineral. It is inexpensive, plentiful, … Continue reading Mesothelioma Risk to War Survivors Highlighted by Journalist’s Case
Targeting Nerve Cells Might Offer New Way to Fight Mesothelioma, Other Cancers
Israeli scientists may have found a new way to fight mesothelioma and other cancers from the inside out by targeting nerve cells. Researchers at Technion – Israel Institute of Technology conducted the new study. It appears in the journal Science Advances. Nerve cells called neurons help promote tumor growth. The team reasoned that targeting these tumor nerve cells with a damaging drug might slow cancer progression. They tested the theory on triple-negative breast cancer tumors in mice. The tumors still grew but they grew much slower than the untreated tumors. The findings could have implications for other hard-to-treat cancers like malignant mesothelioma. New Options Needed for Malignant Mesothelioma Malignant mesothelioma is one of the rarest and most treatment-resistant cancers. Many … Continue reading Targeting Nerve Cells Might Offer New Way to Fight Mesothelioma, Other Cancers
CBD Oil for Mesothelioma? New Case Study Suggests It’s Possible
The case study of a UK lung cancer patient whose tumor shrunk while she was taking CBD oil could be a hopeful sign for mesothelioma patients, too. pleural mesothelioma and non-small cell lung cancer are different disease but they share many commonalities. Both affect the lungs and cause similar symptoms. Sometimes, a treatment that works for NSCLC can help mesothelioma patients and vice versa. The subject of the new case study was a lung cancer patient in her 80s. She went to the doctor for a cough that would not go away. A CT scan showed the woman had a tumor in her right lung. Later, she developed more lung tumors. The patient decided not to have surgery because of … Continue reading CBD Oil for Mesothelioma? New Case Study Suggests It’s Possible
Quinacrine for Mesothelioma? Anti-Malaria Drug May Help Patients with This Gene Mutation
Another study on quinacrine for mesothelioma suggests that the once-popular anti-malaria drug might help a subset of patients with a particular gene mutation. Quinacrine is sold under the brand name Atabrine. It used to be the main anti-malaria drug but most doctors now prefer chloroquine. Last fall, Penn State research on quinacrine for mesothelioma showed the drug has a “high degree of cytotoxicity” on its own. The newest study initially focused on the potential for synergistic effects of quinacrine and chemotherapy. It turns out that the drug can make cisplatin more lethal to mesothelioma cells. Further tests showed that cells with inactivated NF2 mutations were even more sensitive to quinacrine. As many as 60 percent of mesothelioma patients may have … Continue reading Quinacrine for Mesothelioma? Anti-Malaria Drug May Help Patients with This Gene Mutation
Access to Multi-Modality Mesothelioma Treatment Limited for Uninsured & Rural Residents
A new study shows a person’s insurance status and where they live often impact their access to multi-modality mesothelioma treatment. This can have an impact on their survival. Researchers at the University of Miami Sylvester Comprehensive Cancer Center conducted the new study. They shared their findings at the recent virtual world conference of the International Association for the Study of Lung Cancer. The study found that access to multi-modality mesothelioma treatment was more common in patients with private insurance or Medicare. It was also more common among those who lived closer to larger medical centers. People who lived further out or who did not have insurance often did not receive the treatments that offer the best odds of mesothelioma survival. … Continue reading Access to Multi-Modality Mesothelioma Treatment Limited for Uninsured & Rural Residents
Cancer-Fighting Gel Could “Change the Treatment Paradigm” for Mesothelioma
New National Cancer Institute research shows a cancer-fighting gel applied directly to the surface of a mesothelioma tumor could “change the treatment paradigm” for this troublesome cancer. NCI researchers in Maryland developed the treatment and tested it in animals with mesothelioma tumors. Their tests show mesothelioma tumors respond after just one application of the medication. The authors of a new report on the treatment say surgeons could use it to enhance mesothelioma surgery. They could even use the cancer-fighting gel on its own as a stand-alone therapy. The Challenge of Mesothelioma Tumor Shape Malignant mesothelioma is a surface malignancy. Surface malignancies are tumors that grow on the surface of other organs or tissues. In the case of mesothelioma, tumors occur … Continue reading Cancer-Fighting Gel Could “Change the Treatment Paradigm” for Mesothelioma
Second-Line Treatment with Ramucirumab Improves Mesothelioma Survival
New evidence suggests that second-line treatment with ramucirumab after first-line chemotherapy may lead to longer survival in people with pleural mesothelioma. Researchers in Italy recently published results of a double-blind, placebo-controlled trial of the drug. Ramucirumab inhibits a protein mesothelioma tumors need to form new blood vessels. The study included 161 pleural mesothelioma patients from across Italy. Researchers gave half of them second-line treatment with ramucirumab and another drug called gemcitabine. The other half had second-line treatment with gemcitabine alone. Results showed the ramucirumab group lived more than six months longer than those who got only gemcitabine. Few Options for Recurrent Mesothelioma Pleural mesothelioma is an aggressive cancer with few good treatment options. Most patients start with chemotherapy with Alimta. … Continue reading Second-Line Treatment with Ramucirumab Improves Mesothelioma Survival
Study Reveals How TTFields and Chemotherapy Fight Mesothelioma
TTFields and chemotherapy offer one of the most potent combinations against malignant mesothelioma tumors. Now a new study reveals why they work so well together. Tumor Treating Fields (TTFields) are low intensity, intermediate frequency, alternating electric fields. They are delivered into the chest of mesothelioma patients with a vest-like device marketed under the brand name Optune Lua. In 2019, a combination of TTFields and chemotherapy became the first new FDA-approved treatment for mesothelioma in 15 years. Now, a new report in the journal Lung Cancer sheds light on the synergy between the two modes of mesothelioma treatment. Combating Cancer with Electrical Currents The Tumor Treating Fields approach was created by Jersey-based Novocure. The technology uses electrical fields to destabilize critical … Continue reading Study Reveals How TTFields and Chemotherapy Fight Mesothelioma
Physical Function Predicts Mesothelioma Surgery Outcomes
A patient’s level of physical function prior to mesothelioma surgery is a strong predictor of how well they will do after surgery. That is the conclusion of a new University of Maryland study. Researchers analyzed the cases of 54 pleural mesothelioma patients before and after lung-sparing P/D surgery. The goal was to see what factors had the biggest impact on their post-surgical outcomes. Patients underwent lung function and physical function tests both before and after their operations. It turns out that a mesothelioma patient’s ability to be physically active is even more important than their lung function in predicting their recovery. Lung-Sparing Pleural Mesothelioma Surgery Pleural mesothelioma is a cancer of the multi-layer membrane (pleura) that surrounds the lungs. As … Continue reading Physical Function Predicts Mesothelioma Surgery Outcomes
New Tool Measures Stress Levels Among Mesothelioma Caregivers
Preliminary tests of a new tool designed to measure stress levels among mesothelioma caregivers shows that the tool is both reliable and helpful. The tool was developed by occupational medicine researchers in Rome. Their goal was to create a “short, flexible, and comprehensive tool” to detect psychological distress in carers. The team recently tested the tool in a group of mesothelioma caregivers. Their results have just been published in the journal Psycho-Oncology. The Strain of Caring for a Loved One with Mesothelioma Malignant mesothelioma is a highly lethal type of membrane cancer. Most mesothelioma patients lived or worked around asbestos. Pleural mesothelioma is the most common type of mesothelioma. It affects about 2,000 people in the US every year. Another … Continue reading New Tool Measures Stress Levels Among Mesothelioma Caregivers
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."
Get your free copy of
“Surviving Mesothelioma” Today!